Crossmark

E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation

Crossref DOI link: https://doi.org/10.1186/1476-4598-13-84

Published Online: 2014-04-17

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ren, Zijia

Kang, Wenyao

Wang, Lihua

Sun, Baoliang

Ma, Jiajia

Zheng, Chaogu

Sun, Jie

Tian, Zhigang

Yang, Xiaoyi

Xiao, Weihua
More Information

Article History

Received: 15 November 2013

Accepted: 8 April 2014

First Online: 17 April 2014